Present Insights on Cardiomyopathy in Diabetic Patients

Author(s): João Soares Felício, Camila Cavalcante Koury, Carolina Tavares Carvalho, João Felício Abrahão Neto, Karem Barbosa Miléo, Thaís Pontes Arbage, Denisson Dias Silva, Alana Ferreira de Oliveira, Amanda Soares Peixoto, Antônio Bentes Figueiredo, Ândrea Kely Campos Ribeiro dos Santos, Elizabeth Sumi Yamada, Maria Teresa Zanella

Journal Name: Current Diabetes Reviews

Volume 12 , Issue 4 , 2016

Become EABM
Become Reviewer
Call for Editor


The pathogenesis of diabetic cardiomyopathy (DCM) is partially understood and is likely to be multifactorial, involving metabolic disturbances, hypertension and cardiovascular autonomic neuropathy (CAN). Therefore, an important need remains to further delineate the basic mechanisms of diabetic cardiomyopathy and to apply them to daily clinical practice. We attempt to detail some of these underlying mechanisms, focusing in the clinical features and management. The novelty of this review is the role of CAN and reduction of blood pressure descent during sleep in the development of DCM. Evidence has suggested that CAN might precede left ventricular hypertrophy and diastolic dysfunction in normotensive patients with type 2 diabetes, serving as an early marker for the evaluation of preclinical cardiac abnormalities. Additionally, a prospective study demonstrated that an elevation of nocturnal systolic blood pressure and a loss of nocturnal blood pressure fall might precede the onset of abnormal albuminuria and cardiovascular events in hypertensive normoalbuminuric patients with type 2 diabetes. Therefore, existing microalbuminuria could imply the presence of myocardium abnormalities. Considering that DCM could be asymptomatic for a long period and progress to irreversible cardiac damage, early recognition and treatment of the preclinical cardiac abnormalities are essential to avoid severe cardiovascular outcomes. In this sense, we recommend that all type 2 diabetic patients, especially those with microalbuminuria, should be regularly submitted to CAN tests, Ambulatory Blood Pressure Monitoring and echocardiography, and treated for any abnormalities in these tests in the attempt of reducing cardiovascular morbidity and mortality.

Keywords: Diabetic cardiomyopathy, diabetes mellitus, left ventricular hypertrophy, left ventricular dysfunction, ambulatorial blood pressure measurement, diabetic autonomic neuropathy.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 14 September, 2015
Page: [384 - 395]
Pages: 12
DOI: 10.2174/1573399812666150914120529

Article Metrics

PDF: 64